| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8620944 | Journal of Critical Care | 2016 | 7 Pages |
Abstract
Differences in 6-month survival between critically ill patients with different types of active HM were substantial. Recent hematopoietic stem cell transplant, severity of illness, and use of mechanical ventilation were additional important determinants of 6-month survival in patients with an active HM.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Stephen MBBCh, BSc, FCICM, Bradley FACEM, FCICM, MBBS, Matthew MBBS, MPH, FACEM, FCICM, Hasib MBBS, Ashlyn MBBS, Kwok M. MBBS, MPH, MRCP, FANZCA, FJFICM, PhD,